2 active not recruiting, 2 unknown, 1 available. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
| Phase 3 | 2 | Active not recruiting 2 |
Follow Saol Therapeutics Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain SL1002, Normal Saline - Osteoarthritis Knee Pain | Phase 3 | Active not recruiting | Saol Therapeutics Inc | 150 | 2025-11-07 | 2026-10-20 |
| Phase II Study to Assess Safety and Efficacy of SL-1002 for Osteoarthritic Knee Pain SL-1002, Placebo - Osteoarthritis, Knee Pain | Phase 2 | Unknown | Saol Therapeutics Inc | 132 | 2022-06-13 | 2023-08-29 |
| Phase II Study to Assess Safety, Pharmacokinetics and Efficacy of SL-1002 for Limb Spasticity SL-1002, Placebo - Spasticity | Phase 2 | Unknown | Saol Therapeutics Inc | 32 | 2022-04-22 | 2023-09-06 |
| Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency: Dichloroacetate (DCA), Placebo, Genotype - Pyruvate Dehydrogenase Complex Deficiency | Phase 3 | Active not recruiting | Saol Therapeutics Inc | 34 | 2020-07-14 | 2025-05-04 |
| Expanded Access Treatment Protocol With DCA for Patients With PDCD Dichloroacetate (DCA) - Pyruvate Dehydrogenase Complex Deficiency | Available | Saol Therapeutics Inc | 2025-05-08 |
Pyruvate Dehydrogenase Complex Deficiency Disease (2) · Muscle Spasticity (1) · Osteoarthritis (1)
Dichloroacetic Acid (2) · Genotype (1) · Saline Solution (1)
United States (4)
Kiki Diorgu, M.D. (1) · Richard Neibeger, MD (1)